These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4132033)

  • 41. Deutetrabenazine in the treatment of Huntington's disease.
    Richard A; Frank S
    Neurodegener Dis Manag; 2019 Feb; 9(1):31-37. PubMed ID: 30624137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease.
    Heo YA; Scott LJ
    Drugs; 2017 Nov; 77(17):1857-1864. PubMed ID: 29080203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-term effects of tetrabenazine on chorea associated with Huntington's disease.
    Kenney C; Hunter C; Davidson A; Jankovic J
    Mov Disord; 2007 Jan; 22(1):10-3. PubMed ID: 17078062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tetrabenazine for involuntary movement disorders.
    Kingston D
    Med J Aust; 1979 Jun; 1(13):628-30. PubMed ID: 158700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Letter: Treatment of Huntington's chorea.
    Candelise L; Faglioni P; Spinnler H; Vignolo LA
    N Engl J Med; 1973 Nov; 289(22):1201. PubMed ID: 4271092
    [No Abstract]   [Full Text] [Related]  

  • 46. Huntington’s Disease Clinical Trials Corner: February 2018.
    Rodrigues FB; Wild EJ
    J Huntingtons Dis; 2018; 7(1):89-98. PubMed ID: 29480210
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
    Savani AA; Login IS
    Neurology; 2007 Mar; 68(10):797; author reply 797. PubMed ID: 17339599
    [No Abstract]   [Full Text] [Related]  

  • 48. The long-term effect of tetrabenazine in the management of Huntington disease.
    Fasano A; Cadeddu F; Guidubaldi A; Piano C; Soleti F; Zinzi P; Bentivoglio AR
    Clin Neuropharmacol; 2008; 31(6):313-8. PubMed ID: 19050408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug treatment of diseases characterized by abnormal movements.
    Marsden CD
    Proc R Soc Med; 1973 Sep; 66(9):871-3. PubMed ID: 4281483
    [No Abstract]   [Full Text] [Related]  

  • 50. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (HIAA) in the CSF after administration of probenecid in Huntington's chorea. Effect of lithium carbonate].
    Livrea P; Di Reda L; Ragno G; Germinario L; Papagno G
    Riv Neurobiol; 1977; 23(3):149-59. PubMed ID: 154166
    [No Abstract]   [Full Text] [Related]  

  • 51. [Lithium carbonate in Huntington's disease].
    Vardi J; Flechter S; Alelov M; Rabey Y; Streifler M
    Harefuah; 1978 Mar; 94(5-6):168-70. PubMed ID: 149052
    [No Abstract]   [Full Text] [Related]  

  • 52. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
    Jankovic J; Orman J
    Neurology; 1988 Mar; 38(3):391-4. PubMed ID: 3279337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
    Guay DR
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deutetrabenazine for Treatment of Chorea in Huntington Disease.
    Geschwind MD; Paras N
    JAMA; 2016 Jul; 316(1):33-5. PubMed ID: 27380339
    [No Abstract]   [Full Text] [Related]  

  • 55. Letter: G.A.B.A. in Huntington's chorea.
    Fisher R; Norris JW; Gilka L
    Lancet; 1974 Mar; 1(7856):506. PubMed ID: 4131904
    [No Abstract]   [Full Text] [Related]  

  • 56. [Huntington's chorea--report of 29 cases].
    Li ZH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Feb; 18(1):21-3. PubMed ID: 3157553
    [No Abstract]   [Full Text] [Related]  

  • 57. The psychopharmacology of Huntington disease.
    Petersén Å; Weydt P
    Handb Clin Neurol; 2019; 165():179-189. PubMed ID: 31727211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease.
    Dean M; Sung VW
    Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
    Chen JJ; Ondo WG; Dashtipour K; Swope DM
    Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A systematic review of the treatment studies in Huntington's disease since 1990.
    Bonelli RM; Hofmann P
    Expert Opin Pharmacother; 2007 Feb; 8(2):141-53. PubMed ID: 17257085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.